Abstract: A method, system and apparatus are provided to identify, collect and parse content for business intelligence. Particularly, the method, system and apparatus provide for deriving, over a communication network, knowledge from information indicative of human communication, emotions, reactions, and experiences to evaluate trends and decisions that impact business. Also, a system, method and apparatus are provided for processing and analyzing social media conversations via one or more modules communicating with a social cognition technology platform. A module according to an exemplary implementation of the present invention, implements next-generation business intelligence that finds, aggregates, and interprets an exhaustive source of digital Internet content (such as textual and voice conversational, and word-of-mouth content) in conjunction with a social cognition technology platform.

Abstract: Isolated polynucleotides encoding monkey Melanin Concentrating Hormone (MCH) Type 1 receptors and chimeric polypeptides are provided. Vectors and cells for recombinant expression of such MCH1R polypeptides, and isolated MCH1R polypeptides are also provided. MCH1R polynucleotides and polypeptides may be used, for example, to identify compounds that specifically interact with MCH receptor. Such compounds find use within therapies for humans and animals afflicted with conditions associated with MCH receptor activation.

Abstract: Isolated polynucleotides encoding monkey Melanin Concentrating Hormone (MCH) Type 1 receptors and chimeric polypeptides are provided. Vectors and cells for recombinant expression of such MCH1R polypeptides, and isolated MCH1R polypeptides are also provided. MCH1R polynucleotides and polypeptides may be used, for example, to identify compounds that specifically interact with MCH receptor. Such compounds find use within therapies for humans and animals afflicted with conditions associated with MCH receptor activation.

Abstract: Novel chimeric G-protein coupled receptors are provided as isolated polypeptides, membrane preparations containing such chimeric receptors, nucleic acids encoding such chimeric receptors, and cells expressing such receptors. The chimeric receptors are NPY5 receptors with most or all of either one or both of the third cytoplasmic loop domain or the C-terminal intracellular domain of NPY5 replaced with the corresponding region(s) of another NPY receptor, preferably an NPY1 receptor.